These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24378793)

  • 1. Gigi Hirsch. Interview by Asher Mullard.
    Hirsch G
    Nat Rev Drug Discov; 2014 Jan; 13(1):14. PubMed ID: 24378793
    [No Abstract]   [Full Text] [Related]  

  • 2. An audience with Thomas Lönngren. Interview by Asher Mullard.
    Lönngren T
    Nat Rev Drug Discov; 2010 Dec; 9(12):912. PubMed ID: 21119726
    [No Abstract]   [Full Text] [Related]  

  • 3. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 4. Michael Snyder. Interview by Asher Mullard.
    Snyder M
    Nat Rev Drug Discov; 2012 Oct; 11(10):744. PubMed ID: 23023673
    [No Abstract]   [Full Text] [Related]  

  • 5. Mark McClellan. Interview by Asher Mullard.
    McClellan M
    Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796
    [No Abstract]   [Full Text] [Related]  

  • 6. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 7. Stephen Frye. Interview by Asher Mullard.
    Frye S
    Nat Rev Drug Discov; 2012 Apr; 11(5):346. PubMed ID: 22495334
    [No Abstract]   [Full Text] [Related]  

  • 8. Mark Fishman. Interview by Asher Mullard.
    Fishman M
    Nat Rev Drug Discov; 2012 Jan; 11(1):14-5. PubMed ID: 22212670
    [No Abstract]   [Full Text] [Related]  

  • 9. A voyage of discovery.
    Gebel E
    Diabetes Forecast; 2013 Jun; 66(6):50-3. PubMed ID: 23802293
    [No Abstract]   [Full Text] [Related]  

  • 10. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 12. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 13. A need for speed: Signals in drug development.
    Nat Med; 2012 Dec; 18(12):1730-1. PubMed ID: 23223053
    [No Abstract]   [Full Text] [Related]  

  • 14. Breakthrough programme turns two.
    Mullard A
    Nat Rev Drug Discov; 2014 Dec; 13(12):873-5. PubMed ID: 25435204
    [No Abstract]   [Full Text] [Related]  

  • 15. Trevor Mundel. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2012 Mar; 11(4):264-5. PubMed ID: 22460116
    [No Abstract]   [Full Text] [Related]  

  • 16. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 17. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 18. An audience with... Gregory Lip. Interview by Asher Mullard.
    Lip G
    Nat Rev Drug Discov; 2012 Jun; 11(6):434. PubMed ID: 22653207
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerated approval dust begins to settle.
    Mullard A
    Nat Rev Drug Discov; 2011 Oct; 10(11):797-8. PubMed ID: 22037027
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative analysis to guide orphan drug development.
    Lesko LJ
    Clin Pharmacol Ther; 2012 Aug; 92(2):258-61. PubMed ID: 22739138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.